THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.
Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Ketorolac Tromethamine Injection
Status: Currently in Shortage
»Date first posted:
03/23/2018
»Therapeutic Categories: Analgesia/Addiction
Alembic Pharmaceuticals (Revised 08/14/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) | Product available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) | Product available | ||
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) | Product available |
Baxter Healthcare (Revised 09/27/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Limited Supply; Recovery: May 2024 | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Limited supply; Recovery: June 2024 | FOR INTRAVENOUS AND INTRAMUSCULAR USE. 30mg/mL (1 mL fill volume/ 2 mL container) | Demand increase for the drug |
Fresenius Kabi USA (Revised 09/01/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Backordered. Next release not available at this time. | Check wholesaler for inventory. | Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Available | Check wholesaler for inventory. | Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Available | Check wholesaler for inventory | Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Backordered. Next release September 2023. | Check wholesaler for inventory | Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Backordered. Next release September 2023. | Check wholesaler for inventory. | Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Backordered. Next release September 2023. | Check wholesaler for inventory. | Demand increase for the drug |
Gland Pharma Limited (Revised 06/08/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-01) | Available | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-01) | Available | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-02) | Available | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-03) | Available | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-02) | Available | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-04) | Available | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | Available | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | Available | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 05/16/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Unavailable, shortage recovery TBD. | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | Unavailable, shortage recovery TBD. | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | Unavailable, shortage recovery TBD. | Demand increase for the drug |
Hospira, Inc. (Reverified 09/11/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) | Depleted | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Depleted | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 0409-3796-01) | Depleted | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
Sagent Pharmaceuticals (Revised 09/14/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | In stock under NDC 70860-70-002 - 25021-700-01 due week of 9/19/23 | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | In stock under NDC 70860-70-004 -25021-701-02 due week of 9/19/23 | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Backordered. Delivery expected mid-September 2023 | Demand increase for the drug |